BrosMed Medical Announced Japanese Approval and Launch of Rokku Exchange Device In Japan Market
Release time:
2022-11-29
Guangdong, China [Nov. 24, 2022] – BrosMed Medical announced its exchange device has received the Japan PMDA approval.
Guangdong, China [Nov. 24, 2022] – BrosMed Medical announced its exchange device has received the Japan PMDA approval.
BrosMed Medical, a global provider of medical technologies for vascular intervention, has announced Japanese Approval and launch of the Rokku exchange device.
The Rokku exchange device is dedicated to facilitate interventional medical device exchanges without losing wire position and maximize the efficiency of complex cases during PCI procedures.
The Rokku exchange device has a tip to hub core wire design and a fixed wire catheter that has a 10 mm balloon on the distal part. There is a 1 marker band at the tip and another 1 marker band at the proximal balloon edge to facilitate easy placement and identification during rapid exchanges. Rokku is offered in sizes compatible with 6F through 8F guide catheter when at a low inflation pressure. The effective length of this product is 107cm (with a 90 cm guiding catheter) and 117cm (with a 90cm or 100 cm guiding catheter).
BrosMed's Rokku exchange device is an advanced tool to address challenging coronary interventions, enabling the most complicated interventional procedures to be done more efficiently.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
